3858 results for «2338»
3858 results
Latest insights: when to choose orbital atherectomy
20 May 2021 – From EuroPCR 2021
Watch this session presented by Nicolas Van Mieghem, Surendra Avula and Ajay Kirtane in order to understand the challenges of treating severe calcium, to know about the OAS overview with dual-action MOA technology and the clinical evidence supporting its use, and to be introduced to treatment technique.
Sustained Limus release, redefining indications for drug-eluting balloons
20 May 2021 – From EuroPCR 2021
Watch this session presented by Bernardo Cortese, Kambis Mashayekhi, Jonas Häner and Tuomas Rissanen in order to understand how sustained Limus release technology can broaden DEB indications, to learn how SELUTION SLR sustained Limus DEB performs in daily clinical practice, and to know more about the importance of sustained Limus release technology...
EAPCI-PCR Fellows Course: interventions for calcified coronary lesions
18 May 2021 – From EuroPCR 2021
Watch this session if you want to review the role of imaging for procedural planning and to discuss the best indications for specific plaque modification techniques.
This session was originally presented during EuroPCR 2021.
Cardiovascular Innovation Pipeline: Transcatheter Mitral Replacement Devices
18 May 2021 – From EuroPCR 2021
Mitral regurgitation is a leading cause of valvular heart disease in Western countries. Transcatheter mitral valve replacement (TMVR) has emerged as a potential therapeutic option for patients with severe mitral disease who are at high risk for conventional surgery. Watch these presentations to find out about...
Complete 2-year follow-up from the Evolut low risk trial
18 May 2021 – From EuroPCR 2021
This session was originally presented during EuroPCR 2021.
Presentation of the PCR Tricuspid Focus Group
19 May 2021 – From EuroPCR 2021
This session was originally presented during EuroPCR 2021.
Endovascular aortic repair and case-based discussion of complications during peripheral interventions (Part 1)
20 May 2021 – From EuroPCR 2021
Watch this session if you want to learn more about Endovascular aortic repair and complications during peripheral interventions. It highlights the need for a large toolbox and the importance of pre-procedural planning, ultrasound-guided puncture, and team-working (vascular/heart teams).
This session was originally presented during EuroPCR 2021.
EAPCI-PCR Fellows Course: your first TAVI procedure - Session with LIVE demonstration
19 May 2021 – From EuroPCR 2021
Watch this session if you want to learn how to assess a CT scan for a TAVI procedure, to master large bore vascular access and closure, and to learn how to cross the aortic valve and position the valvular prosthesis.
This session was originally presented during EuroPCR...
Managing a patient with STEMI and bystander disease in the pandemic (Part 2) - Session with LIVE case
20 May 2021 – From EuroPCR 2021
Watch this session if you want to be updated on developments in treatment of ACS and STEMI, and to discuss diagnosis and treatment for bystander disease.
This session was originally presented during EuroPCR 2021.
EuroPCR 2021 - Innovations in peripheral and structural interventions
18 May 2021 – From EuroPCR 2021
In this session, discover how an effective calcium debridement procedure in stenotic aortic valves may restore the valve function, and why biometric indicators and engineering characteristics are so important for effective and safe delivery of endovascular care.
Percutaneous tricuspid valve repair: how to perform it - Session with LIVE demonstration
19 May 2021 – From EuroPCR 2021
Watch this session if you want to learn how to select patients, to understand how to perform a percutaneous tricuspid repair and to gain tips and tricks.
This session was originally presented during EuroPCR 2021.
Current status of renal denervation techniques for the treatment of hypertension (Part 1)
19 May 2021 – From EuroPCR 2021
Watch this session if you want to review the up-to-date indications, device selection and procedural techniques for renal denervation.
This session was originally presented during EuroPCR 2021.
EuroPCR 2018 Closing Ceremony
25 May 2018 – From EuroPCR 2018
Consult the session video on the Closing Ceremony of EuroPCR 2018 presented by A. Baumbach.
EuroPCR 2018 Opening Ceremony and Ethica Awards
22 May 2018 – From EuroPCR 2018
Join J. Fajadet and W. Wijns for the EuroPCR 2018 Opening Ceremony and find out who this year's Ethica Awards winners are!
Closing Ceremony and Highlights of the Course: PCR London Valves 2018
11 Sep 2018 – From PCR London Valves 2018
Join B. Prendergast for the closing ceremony of PCR London Valves 2018 and discover the course highlights!
Opening Ceremony: PCR London Valves 2018
10 Sep 2018 – From PCR London Valves 2018
Join J. J. Bax, B. Prendergast and J. Fajadet for the opening ceremony of PCR London Valves 2018 and find out more about the global challenge of the increasing burden of heart disease and the new technologies for the treatment of SHD.
Most interesting novel devices for the treatment of valvular heart disease
17 Feb 2019 – From PCR Tokyo Valves 2019
Consult this session to learn more about innovative perspectives for the interventional treatment of valvular heart disease, and discover some new devices which may truly impact your practice of transcatheter valve therapies in the future.
Complications of TAVI
17 Feb 2019 – From PCR Tokyo Valves 2019
Consult this session to learn more about how to identify which patients are high risks for complication, how to use imaging in procedural planning, and how to treat TAVI related complications (valve embolization, paravalvular leak, and more!).
Closing Ceremony - PCR Tokyo Valves 2019
17 Feb 2019 – From PCR Tokyo Valves 2019
Consult this session to discover the slides of the PCR Tokyo Valves 2019 closing ceremony, including the best clinical case presenters awards.
Hot topics in the pharmacologic treatment after TAVI – Current concepts
16 Feb 2019 – From PCR Tokyo Valves 2019
Consult this session to learn more about the risk of valve thrombosis, thrombo-embolic and bleeding events after TAVI and the rationale of antithrombotic treatment regimens in atrial fibrillation patients post TAVI.
